Camp4 Therapeutics Poration Stock Buy Hold or Sell Recommendation
| CAMP Stock | USD 4.62 0.17 3.82% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding CAMP4 THERAPEUTICS PORATION is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell CAMP4 THERAPEUTICS PORATION within the specified time frame.
Check out CAMP4 THERAPEUTICS Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as CAMP4 and provide practical buy, sell, or hold advice based on investors' constraints. CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
CAMP4 |
Execute CAMP4 THERAPEUTICS Buy or Sell Advice
The CAMP4 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on CAMP4 THERAPEUTICS PORATION. Macroaxis does not own or have any residual interests in CAMP4 THERAPEUTICS PORATION or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute CAMP4 THERAPEUTICS's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
CAMP4 THERAPEUTICS Trading Alerts and Improvement Suggestions
| CAMP4 THERAPEUTICS generated a negative expected return over the last 90 days | |
| CAMP4 THERAPEUTICS has high historical volatility and very poor performance | |
| CAMP4 THERAPEUTICS has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 186.23 M. Net Loss for the year was (49.29 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| CAMP4 THERAPEUTICS PORATION currently holds about 47.72 M in cash with (44.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29. |
CAMP4 THERAPEUTICS Returns Distribution Density
The distribution of CAMP4 THERAPEUTICS's historical returns is an attempt to chart the uncertainty of CAMP4 THERAPEUTICS's future price movements. The chart of the probability distribution of CAMP4 THERAPEUTICS daily returns describes the distribution of returns around its average expected value. We use CAMP4 THERAPEUTICS PORATION price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of CAMP4 THERAPEUTICS returns is essential to provide solid investment advice for CAMP4 THERAPEUTICS.
| Mean Return | -0.31 | Value At Risk | -17.56 | Potential Upside | 17.91 | Standard Deviation | 13.77 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of CAMP4 THERAPEUTICS historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
CAMP4 THERAPEUTICS Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (12.8M) | (15.4M) | (37.3M) | (44.5M) | (51.2M) | (53.8M) | |
| Free Cash Flow | 17.2M | (17.5M) | (34.0M) | (44.8M) | (40.3M) | (38.3M) | |
| Depreciation | 22.0M | 22.8M | 21.8M | 1.7M | 1.5M | 1.4M | |
| Other Non Cash Items | 1.4M | 9.8M | 2.0M | 1.8M | 1.6M | 1.6M | |
| Capital Expenditures | 11.4M | 13.3M | 11.1M | 678K | 610.2K | 579.7K | |
| Net Income | (21.2M) | (31.1M) | (32.5M) | (49.3M) | (56.7M) | (59.5M) | |
| End Period Cash Flow | 94.6M | 79.2M | 41.9M | 40.0M | 36.0M | 58.1M |
CAMP4 THERAPEUTICS Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to CAMP4 THERAPEUTICS or Communications Equipment sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that CAMP4 THERAPEUTICS's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a CAMP4 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.39 | |
β | Beta against Dow Jones | 3.46 | |
σ | Overall volatility | 14.15 | |
Ir | Information ratio | -0.02 |
CAMP4 THERAPEUTICS Volatility Alert
CAMP4 THERAPEUTICS PORATION is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure CAMP4 THERAPEUTICS's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact CAMP4 THERAPEUTICS's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.CAMP4 THERAPEUTICS Fundamentals Vs Peers
Comparing CAMP4 THERAPEUTICS's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze CAMP4 THERAPEUTICS's direct or indirect competition across all of the common fundamentals between CAMP4 THERAPEUTICS and the related equities. This way, we can detect undervalued stocks with similar characteristics as CAMP4 THERAPEUTICS or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of CAMP4 THERAPEUTICS's fundamental indicators could also be used in its relative valuation, which is a method of valuing CAMP4 THERAPEUTICS by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare CAMP4 THERAPEUTICS to competition |
| Fundamentals | CAMP4 THERAPEUTICS | Peer Average |
| Price To Earning | 318.57 X | 28.72 X |
| Revenue | 186.23 M | 9.43 B |
| EBITDA | (8.72 M) | 3.9 B |
| Net Income | (49.29 M) | 570.98 M |
| Cash And Equivalents | 47.72 M | 2.7 B |
| Cash Per Share | 1.29 X | 5.01 X |
| Total Debt | 178.68 M | 5.32 B |
| Current Ratio | 1.86 X | 2.16 X |
| Book Value Per Share | (45.01) X | 1.93 K |
| Cash Flow From Operations | (44.16 M) | 971.22 M |
| Earnings Per Share | (63.02) X | 3.12 X |
| Price To Earnings To Growth | 0.08 X | 4.89 X |
| Target Price | 14.18 | |
| Number Of Employees | 58 | 18.84 K |
| Beta | 1.89 | -0.15 |
| Market Capitalization | 660.34 K | 19.03 B |
| Total Asset | 54.95 M | 29.47 B |
| Retained Earnings | (159.96 M) | 9.33 B |
| Working Capital | 32.21 M | 1.48 B |
| Current Asset | 298.77 M | 9.34 B |
| Current Liabilities | 49.56 M | 7.9 B |
| Net Asset | 54.95 M |
Note: Disposition of 1534 shares by Nathan Lowstuter of CAMP4 THERAPEUTICS subject to Rule 16b-3 [view details]
CAMP4 THERAPEUTICS Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as CAMP4 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About CAMP4 THERAPEUTICS Buy or Sell Advice
When is the right time to buy or sell CAMP4 THERAPEUTICS PORATION? Buying financial instruments such as CAMP4 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having CAMP4 THERAPEUTICS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.